DENGUE IN CHILDREN: CLINICAL AND EPIDEMIOLOGICAL ASPECTS IN THE CITY OF CASCAVEL, PARANÁ, FROM 2014 TO 2022
DOI:
https://doi.org/10.47820/recima21.v4i10.4147Keywords:
Dengue. Children. Epidemiology.Abstract
Introduction: Diagnosing dengue in children remains a challenge, especially in the early stages, due to the overlap of clinical symptoms with various other common childhood illnesses. Objectives: To describe the clinical and epidemiological aspects of dengue in children in the municipality of Cascavel, Paraná, from 2014 to 2022. Methodology: This is a descriptive, quantitative, and retrospective study conducted in the municipality of Cascavel, Paraná, using data available in the SINAN (Sistema de Informação de Agravos de Notificações). Results and Discussion: The results revealed a predominance of cases in male patients (n = 1,620; 55.12%), of white ethnicity (n = 2,226; 75.74%), and in the age group of 10 to 14 years (n = 1,490 cases; 50.69%). However, the age group of children under 1 year of age was proportionally the most affected, especially in terms of hospitalizations (13.45%). The year 2022 recorded the highest number of notifications (n = 1,529), and the months of March and April maintained the typical seasonality of the disease, with a higher incidence of cases. Conclusion: These data provide insights for the development of strategies focused on dengue prevention and control, with a special emphasis on protecting children, who are a vulnerable group to this disease.
Downloads
References
ABE, A. H.M.; MARQUES, S. M.; COSTA, P. S. S. Dengue em crianças: da notificação ao óbito. Revista Paulista de Pediatria, v. 30, p. 263-271, 2012.
BHATT, S. et al. The global distribution and burden of dengue. Nature [Internet]. 2013.
BRASIL, M. da S. Dengue: diagnóstico e manejo clínico–Adulto e Criança. 2011.
COBRA, Claudine et al. Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico, 1990–1991. American journal of epidemiology, v. 142, n. 11, p. 1204-1211, 1995.
DAL’BOSCO, A.; HENRIQUES, L. L.; CORTEZ, L. E. R. Dengue em crianças: análise da ocorrência da região da Amusep no período de 2007–2015. VII Amostra Interna de Trabalhos de Iniciação Científica. Maringá, Paraná, Brasil, 2016.
DUNCAN, Bruce B. et al. Medicina ambulatorial: condutas de atenção primária baseadas em evidências. In: Medicina ambulatorial: condutas de atenção primária baseadas em evidências. 2013. p. 1952-1952.
ENDY, Timothy P. et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. American journal of epidemiology, v. 156, n. 1, p. 40-51, 2002.
FIGUEIREDO, L. T. M. Dengue in Brazil. Rev Soc Bras Med Trop. 2012;45(3):285-5.
FREIRE, D. M. G. et al. Dengue em crianças: Aspectos epidemiológicos no estado do Rio de janeiro entre 2005 e 2014. Revista de Saúde, v. 8, n. 1, p. S1, 2017.
GUZMAN, Maria G. et al. Multi-country evaluation of the sensitivity and specificity of two commercially-available NS1 ELISA assays for dengue diagnosis. PLoS neglected tropical diseases, v. 4, n. 8, p. e811, 2010.
FUZMÁN, María Guadalupe; VÁZQUEZ, Susana; KOURI, Gustavo. Dengue: where are we today?. The Malaysian journal of medical sciences: MJMS, v. 16, n. 3, p. 4, 2009.
HUITS, Ralph et al. Clinical utility of the nonstructural 1 antigen rapid diagnostic test in the management of dengue in returning travelers with fever. In: Open forum infectious diseases. US: Oxford University Press, 2017. p. ofw273.
HUNSPERGER, Elizabeth A. et al. Performance of dengue diagnostic tests in a single-specimen diagnostic algorithm. The Journal of infectious diseases, v. 214, n. 6, p. 836-844, 2016.
JAIN, Amita; CHATURVEDI, Umesh C. Dengue in infants: an overview. FEMS Immunology & Medical Microbiology, v. 59, n. 2, p. 119-130, 2010.
KALAYANAROOJ, S. Choice of colloidal solutions in dengue hemorrhagic fever patients. J Med Assoc Thai, v. 91, n. Suppl 3, p. S97-103, 2008.
KALAYANAROOJ, Siripen; CHANSIRIWONGS, Vanya; NIMMANNITYA, Suchitra. Dengue Patients at the Children's Hospital, Bangkok: 1995-1999 Review. 2002.
KULARATNE, S. A. Dengue fever. Bmj, v. 351, 2015.
KULARATNE, S. A.; DALUGAMA, C. Dengue infection: Global importance, immunopathology and management. Clinical Medicine, v. 22, n. 1, p. 9, 2022.
L’AZOU, M. et al. Symptomatic dengue in children in 10 Asian and Latin American countries. New England Journal of Medicine, v. 374, n. 12, p. 1155-1166, 2016.
MINISTRY OF HEALTH - SRI LANKA. Guidelines on Management of Dengue Fever &. Dengue Haemorrhagic Fever in adults. National Guidelines, 2012.
NGUYEN, N. M. et al. A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. The Journal of infectious diseases, v. 207, n. 9, p. 1442-1450, 2013.
ROCHA, L. A.; TAUIL, P. L. Dengue em criança: aspectos clínicos e epidemiológicos, Manaus, Estado do Amazonas, no período de 2006 e 2007. Revista da Sociedade Brasileira de Medicina Tropical, v. 42, p. 18-22, 2009.
SIQUEIRA JR, J. B. et al. Dengue and dengue hemorrhagic fever, Brazil, 1981–2002. Emerging infectious diseases, v. 11, n. 1, p. 48, 2005.
SIQUEIRA JR, J. B. et al. Dengue no Brasil: tendências e mudanças na epidemiologia, com ênfase nas epidemias de 2008 e 2010. Saúde Brasil, v. 10, 2010.
TEMPORÃO, J. G. et al. Dengue virus serotype 4, Roraima state, Brazil. Emerging infectious diseases, v. 17, n. 5, p. 938, 2011.
THOMAS, S. J. et al. Dengue virus infection: Prevention and treatment. UpToDate. Waltham MA: UpToDate Inc, 2019.
WORLD HEALTH ORGANIZATION et al. Dengue: guidelines for diagnosis, treatment, prevention and control. World Health Organization, 2009.
Downloads
Published
License
Copyright (c) 2023 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
